Results 201 to 210 of about 12,956 (251)

Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver. [PDF]

J Pharm Biomed Anal
Qin X, Chen S, Hakenjos JM, Wang J, Guo L, Dogra A, Hu Z, MacKenzie KR, Li F.   +8 more
europepmc   +1 more source

Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis. [PDF]

J Inherit Metab Dis
Bouwhuis N, Majait S, Polak Y, de Jong A, Jacobs BAW, Vaz FM, Leen WG, Kemper EM, Swart EL, Hollak CEM.   +9 more
europepmc   +1 more source

Cross-Signal Contribution as a Challenge in LC-MS/MS Bioanalysis. [PDF]

Anal Chem
Siemiątkowska A, Kosicka-Noworzyń K, Karaźniewicz-Łada M, Park C, Gershkovich P, Kagan L.   +5 more
europepmc   +1 more source

Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology Screening. [PDF]

Drug Test Anal
Frankenfeld F, Wagmann L, Meyer MR.
europepmc   +1 more source

Morusin as a drug candidate: opportunities, limitations, and the path toward clinical translation. [PDF]

Front Pharmacol
Azzam HN, El-Dessouki AM, Attallah KA, Sadek MA, Aboulmagd YM, Hassan MM, Fahmy MI, El-Shiekh RA, Kamal RM, Khalifa HO.   +9 more
europepmc   +1 more source

Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis. [PDF]

J Physiol Biochem
Beaumont P, Amintas S, Krisa S, Courtois A, Richard T, Eseberri I, Portillo MP.   +6 more
europepmc   +1 more source

The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. [PDF]

Int J Cancer
Larnder AH, Manges AR, Murphy RA.
europepmc   +1 more source

Human cytochrome P450 enzymes catalyze oxidative metabolism of pectolinarigenin to generate a more active Nrf2 agonist. [PDF]

Chin Herb Med
Liu P, Deng Y, Tu D, Gong J, Zhang F, Liu H, Li Q, Hu J, Ge G.   +8 more
europepmc   +1 more source

The second life of Citrus bergamia: bioavailability analysis of a new formulation using waste-based microencapsulation as a valuable source of bioactive compounds. [PDF]

Pharmacol Rep
Serra M, Macrì R, Bonacci S, Ritorto G, Ussia S, Nucera S, Caminiti R, Ruga S, Altomare C, Tucci L, Trunfio G, Cosco D, Procopio A, Muscoli C, Mollace R, Mollace V.   +15 more
europepmc   +1 more source